↓ Skip to main content

Autologous dendritic cell immunotherapy (DCVAC/PCa) added to docetaxel chemotherapy in a Phase III trial (viable) in men with advanced (mCRPC) prostate cancer

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2015
Altmetric Badge

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
10 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Autologous dendritic cell immunotherapy (DCVAC/PCa) added to docetaxel chemotherapy in a Phase III trial (viable) in men with advanced (mCRPC) prostate cancer
Published in
Journal for Immunotherapy of Cancer, November 2015
DOI 10.1186/2051-1426-3-s2-p164
Authors

Tomasz M Beer, Nicholas Vogelzang, Jiřina Bartůňková, Kurt Miller, William Oh, Stephane Oudard, Hardev Pandha, A Oliver Sartor, Radek Špíšek, Timothy O Toole, Niels G Borgstein, Winald R Gerritsen

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 10 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 20%
Other 1 10%
Student > Doctoral Student 1 10%
Lecturer 1 10%
Student > Ph. D. Student 1 10%
Other 1 10%
Unknown 3 30%
Readers by discipline Count As %
Medicine and Dentistry 2 20%
Pharmacology, Toxicology and Pharmaceutical Science 1 10%
Immunology and Microbiology 1 10%
Nursing and Health Professions 1 10%
Unknown 5 50%